This site has limited support for your browser. We recommend switching to Edge, Chrome, Safari, or Firefox.

FREE SHIPPING OVER €50 · DESIGNED IN MUNICH

Use code WELCOME15 to get 15% off your first order.

Shopping Cart 0

Congratulations! Your order qualifies for free shipping Only €50,00 left for free shipping.
No more products available for purchase

Products
Pair with
Is this a gift?
Subtotal Free
Shipping, taxes, and discount codes are calculated at checkout

Has the secret of eternal youth finally been unlocked?

Lächelnde Frau mit weißem Haarband hält auf einem Boot am Meer einen Beutel NMN Pulver von LongevityLife

Scientists at Harvard take it every day. Early human studies confirm what decades of animal research had suggested. The longevity molecule that the world's leading researchers have been studying for twenty years is finally here. This is what science really says.

The fountain of youth is a human obsession, as old as humanity itself. Every civilization, every era, every generation had its own version of it—the elixir, the spring, the ritual, the cure. Most of them turned out to be wishful thinking disguised as discovery. What is happening now in longevity research is different. Not because science has found immortality. But because it has found something that really shouldn't exist: a measurable, reversible biological mechanism of aging. And a molecule that targets exactly that.

The molecule is NAD+. The intervention is NMN. And the scientists researching it are not at the fringes of their field. They research at Harvard, the Washington University School of Medicine, and the University of Tokyo. They publish in Science, Nature, and Cell Metabolism. And some of them take NMN themselves.

The molecule that changed how science thinks about aging

NAD+, short for nicotinamide adenine dinucleotide, has been known to science for over a century. What has changed in the last two decades is the understanding of what its decline actually means. In 2013, a groundbreaking study from David Sinclair's lab at Harvard Medical School showed that raising NAD+ levels in aging mice reversed vascular aging, improved mitochondrial function, and resulted in measurable improvements in muscle strength and endurance. The mice didn't just slow down their aging. They reversed its markers.

Then NAD+ research accelerated dramatically. Shin-ichiro Imai at the Washington University School of Medicine developed a conceptual model called NAD World—the idea that NAD+ acts as a crucial systemic signaling molecule that maintains the biological robustness of the entire body's communication network.

His team's work over the following decade established NMN as the most direct and efficient precursor of NAD+ and showed that oral supplementation can restore NAD+ levels in aging mammals with measurable, consistent results.

NMN could improve the metabolism of adults and make it more like that of a person ten or twenty years younger.

Dr. Shin-ichiro Imai, MD, PhD

The reason this is so important lies in what NAD+ actually does. It drives over 500 enzymatic reactions in the human body. It is needed so that mitochondria can produce energy. It activates sirtuins, a family of proteins directly linked to longevity, inflammation regulation, and DNA repair.

It regulates the internal clock. It is involved in the synthesis of sex hormones. It controls the metabolism of immune cells. When NAD+ declines—and it declines in every adult by their mid-twenties, reaching about half its peak level by middle age—all these systems simultaneously become less efficient. The result is what most people simply call aging.

What twenty years of research has actually proven

Animal research on NAD+ and NMN is extensive and remarkably consistent. In mice, NMN supplementation suppressed age-related weight gain, increased energy metabolism, improved insulin sensitivity, restored skeletal muscle, improved eye function, protected the heart from damage, slowed cognitive decline in Alzheimer's models, and extended lifespan markers. The results from dozens of independent studies point in the same direction—with a consistency unusual for a biological intervention.

Human studies emerged starting in 2020, and the data, although earlier in the stage than animal research, are promising. The most significant study to date examined 25 postmenopausal women in a randomized, placebo-controlled, double-blind trial and found significant improvements in muscle insulin sensitivity after 10 weeks of daily NMN supplementation.

Another twelve-week study found improvements in sleep quality and physical performance. A study on amateur runners showed that NMN significantly improved oxygen efficiency and aerobic capacity. In these studies, NAD+ blood levels increased measurably within a few weeks after starting supplementation.

Clinically, some patients report more energy, better recovery, and sharper cognitive performance. Animal studies show promising longevity effects, but human studies are still in an early stage.

Dr. Elliot Dinetz, MD

Why the scientists researching it take it themselves

In pharmaceutical research, it is unusual for scientists to take their own experimental compounds. It happens when the evidence is compelling enough that waiting for decades-long studies seems like an unnecessary delay.

David Sinclair, Harvard's most prominent longevity researcher, has publicly stated that he takes NMN every day. He said his lipid profile had dramatically improved, he felt more energetic, and his blood levels at almost 60 years old were closer to those of a 31-year-old. Shin-ichiro Imai's team at Washington University has expressed similar confidence in the direction of the research.

This is not a scientist recommending a dietary supplement—it is the person leading the studies deciding that the precautionary principle works both ways: that the risk of not addressing the NAD+ decline is higher than the risk of addressing it with the safest, best-researched intervention available.

His blood levels at almost 60 years old are closer to those of a 31-year-old.

-About David Sinclair, longevity researcher at Harvard Medical School, and his own NMN protocol

Why this means more for women than headlines suggest

Most debates about longevity revolve around aging in general. The specific effects on women are more urgent and are discussed far less frequently. The NAD+ decline in women does not happen in isolation. It happens alongside hormonal changes—perimenopause can begin as early as 35, menopause occurs on average at 51 to 52 years old—and both processes reinforce each other in a way that is still underrepresented in research.

The enzyme responsible for producing progesterone requires NAD+ as a cofactor. This means: the hormonal symptoms of perimenopause—the brutal luteal phase, worsening PMS, mood swings, disrupted sleep phases—are not purely hormonal in origin. They are also cellular. Addressing the NAD+ decline does not replace hormonal support where it is needed, but it addresses a dimension of women's hormonal health that has been almost entirely missing from clinical discussion until now.

Women's health research receives less than 1% of the global medical research budget. The first human study on NMN specifically conducted in women was published in 2021. There is a direct connection between these two facts.

So, was eternal youth actually discovered?

No. And anyone who tells you otherwise is selling you something even more aggressively than we are. Aging is not a single mechanism, and NMN does not completely reverse it. What has been discovered is something more specific and probably more useful: one of the primary biological drivers of aging, a molecule whose decline explains a remarkable portion of what we experience as getting older, and a direct intervention that measurably restores it.

This is not immortality. But it is the most scientifically credible intervention in the field of aging that currently exists. The gap between "eternal youth" and "the currently best-supported biological intervention against age-related decline" is large in mythology and small in practical everyday life for the 38-year-old woman who is exhausted in a way she cannot explain.

The bottom line

Eternal youth has not been discovered. What has been discovered is that aging has a biological mechanism, that this mechanism is linked to the decline of NAD+, and that NMN is the most direct, best-researched intervention that targets it. For women in particular, the effects extend into hormonal health, sleep, recovery, cognitive performance, and metabolism—in a way that research is only just beginning to fully map.

Sources:

  • Covarrubias, A. J., Perrone, R., Grozio, A., & Verdin, E. (2021). NAD+ metabolism and its roles in cellular processes during ageing. Nature Reviews Molecular Cell Biology, 22(2), 119–141. https://doi.org/10.1038/s41580-020-00313-x
  • Grozio, A., Mills, K. F., Yoshino, J., et al. (2019). Slc12a8 is a nicotinamide mononucleotide transporter. Nature Metabolism, 1(1), 47–57. https://doi.org/10.1038/s42255-018-0009-4
  • Imai, S. I., & Guarente, L. (2014). NAD+ and sirtuins in aging and disease. Trends in Cell Biology, 24(8), 464–471. https://doi.org/10.1016/j.tcb.2014.04.002
  • Kim, M., Seol, J., Sato, T., et al. (2022). Effect of 12-week intake of NMN on sleep quality, fatigue, and physical performance. Nutrients, 14(4), 755. https://doi.org/10.3390/nu14040755
  • Liao, B., Zhao, Y., Wang, D., et al. (2021). NMN supplementation enhances aerobic capacity in amateur runners. JISSN, 18(1), 54. https://doi.org/10.1186/s12970-021-00442-4
  • Massudi, H., Grant, R., Braidy, N., et al. (2012). Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. PLOS ONE, 7(7), e42357. https://doi.org/10.1371/journal.pone.0042357
  • Mills, K. F., Yoshida, S., Stein, L. R., et al. (2016). Long-term administration of NMN mitigates age-associated physiological decline in mice. Cell Metabolism, 24(6), 795–806. https://doi.org/10.1016/j.cmet.2016.09.013
  • Shade, C. (2020). The science behind NMN: A stable, reliable NAD+ activator. Integrative Medicine, 19(1), 12–14.
  • Yoshino, M., Yoshino, J., Kayser, B. D., et al. (2021). Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science, 372(6547), 1224–1229. https://doi.org/10.1126/science.abe9985